The Cell & Gene Therapy – From Innovation To Market Growth
In 2023, the market for cell and gene therapy was worth USD 18.8 billion. In the years to come, the market is projected to...
Advances And Challenges In The Gene Therapy Manufacturing
Cell and gene treatments are now one of the pharmaceutical industry’s fastest-growing segments, with more and more being investigated for a variety of purposes.
The...
Impact of AI On Drug Development And Discovery Process
Since artificial intelligence (AI) has the exciting potential to transform every sector and change established processes, it is now the talk of the town....
Dosing Gets Further Precision With New Drug Delivery Tech
Throughout the last four to five years, there has been a persistent problem, which was noted by Willus Fisher, a doctoral candidate at UC...
Understanding And Addressing Drug Shortage Issues In The EU
The European Commission has released findings from a pilot study aimed at understanding the difficulties in ensuring secure drug supply chains. According to the...
The Role of Partnerships In Managing Clinical Trial Costs
Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success.
At the 13th Annual Clinical...
Insights Into $3.72B Clinical Trial Supplies Market By 2028
The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...